Background Patients hospitalized with COVID-19 often exhibit markers of a hypercoagulable
state and have an increased incidence of VTE. In response, CHEST issued rapid clinical …

A common and potent consideration has recently entered the landscape of the novel
coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has …

Many aspects of care such as management of hypercoagulable state in COVID-19 patients,
especially those admitted to intensive care units is challenging in the rapidly evolving …

Introduction An individualised thromboprophylaxis was implemented in critically ill patients
suffering from coronavirus disease 2019 (COVID-19) pneumonia to reduce mortality and …

Background Infection with coronavirus SARS-CoV-2, causing COVID-19 disease, leads to
inflammation and a prothrombotic state. Objective This rapid systematic review aims to …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Background: Recent studies revealed a high prevalence of venous thromboembolism (VTE)
events in coronavirus disease 2019 (COVID-19) patients, especially in those who are …

Background Coronavirus disease 2019 (COVID-19) increases thrombosis in hospitalized
patients prompting adoption of different thromboprophylaxis strategies. Safety and efficacy of …

Background Because of the high risk of thrombotic complications (TCs) during SARS-CoV-2
infection, several scientific societies have proposed to increase the dose of preventive …

Abstract Background: COVID-19–related critical illness is associated with an increased risk
of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the …